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Radiation Planning Index for dose distribution 
evaluation in stereotactic radiotherapy
Krzysztof ŚLOSAREK1, Aleksandra GRZĄDZIEL1, Marta SZLAG1, 
Joanna BYSTRZYCKA1
SUMMARY
AIM: The aim of this study was to provide a parameter for treatment plan comparisons in clinical 
practice. 
MATERIALS AND METHODS: 21 patients with brain tumours were selected for analysis. Two alterna-
tive treatment plans were calculated for each patient. One of the alternative plans was approved while 
the second one was rejected by the physician. Alternative plans were compared with the parameter 
RPI. The computer program RPIWin® was prepared to facilitate the calculation process. 
RESULTS: Calculations showed that 80% of approved treatment plans had higher RPI than rejected 
ones. Only 4 cases of approved treatment plans were characterized by lower RPI values than rejected 
ones.
CONCLUSION: The experiment demonstrated that the Radiation Planning Index formula takes into ac-
count the relation between dose distributions calculated for planning treatment volumes and organs 
at risk and is a convenient tool for treatment plan comparisons in routine clinical practice.
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BACKGROUND
Conformal radiotherapy is a balance between 
the prescribed dose delivered to the tumour 
volume and healthy tissue tolerance [1, 2, 3, 
4, 5, 6, 7].  
Nowadays the choice of the optimal treat-
ment plan among a number of plans calculated 
for the same patient in modern radiotherapy 
is challenging and is based on the experience 
and knowledge of the physician and radiother-
apists.
However, such estimation seems highly 
subjective, and for this reason we believe that 
an unambiguous index that ranks the dose dis-
tribution will benefi t the decision-making pro-
cess [8, 9, 10, 11].
Numerous indices that characterize the 
dose distribution in the planning treatment 
volume (PTV) are widely reported in the lit-
erature, e.g. the conformal index, which ana-
lyzes the relation between the prescribed dose 
in PTV, and organs at risk (OAR) [12, 13, 14]. 
However, most parameters take into consider-
ation only the reference dose value and single 
PTV. None of the parameters takes into ac-
count complicated relations between the dose 
distribution in the set of PTVs and OAR intro-
duced to the plan. 
We believe that the Radiation Planning In-
dex (RPI) is a convenient tool for comparison 
of treatment plans in routine clinical prac-
tice.
AIM
The aim of this study was to introduce the RPI 
formula and to develop a method for compari-
son of dose distributions calculated in IMRT 
technique.
MATERIALS AND METHODS
21 patients with brain tumours treated with 
stereotactic radiosurgery were selected for 
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analysis. For each patient 2 alternative treat-
ment plans were calculated by the BrainLab 
BrainScan treatment planning system. Both 
treatment plans were presented to the phy-
sician. One of the alternative plans was ap-
proved for treatment while the second one was 
rejected.
Each pair of treatment plans contained 
from 1 to 2 PTV contours and from 3 to 6 OAR. 
The Radiation Planning Index (RPI) was cal-
culated for each analyzed plan.
For the purpose of this study the following 
RPI formula (Eq. 1) was proposed as an evalu-
ation tool of the decision-making process.
RPI is the Radiation Planning Index, where 
n is the number of critical structures (OAR) 
and m is the number of volumes treated 
(PTV). 
Integral doses in RPI are based on the dose 
volume histograms (DVHs) (Fig 1.) calculated 
for each OAR and PTV.
is the integral dose of the j-th OAR, while
is the integral dose of the OARj volume, assum-
ing that the whole volume receives the tolerance 
dose for this critical structure (Fig. 1). Similarly 
is the integral dose of the i-th PTV and 
is the integral dose of the i-th PTV, assuming 
that the whole volume is homogeneously cov-
ered with the prescribed dose value.
SDev determines the standard deviation 
of the dose distribution in PTV, while pi is a 
weight factor of the dose distribution homoge-
neity for the PTVi. Each OAR is characterized 
by the importance factor wj. The importance 
factor was introduced to RPI to rank organs 
sensitive to irradiation. Its value is established 
individually for each patient based on the phy-
sician’s and dosimetrist’s experience, organ’s 
radiosensitivity and patient’s history of irra-
diation.
D max OaR is the maximal dose value, 
which should not exceed the tolerance dose for 
the selected anatomical structure.
When  
then  
It results in RPI = 0 because the whole OAR 
is covered with the maximal tolerance dose. 
If the integral dose in PTV is much lower 
than the prescribed reference dose then 
which results in RPI – > 0.
Fig. 1. Dose-volume histogram for OAR represents two 
dimensional coverage of the irradiated volume. Solid line 
represents ideal, homogeneous coverage of the irradiated 
volume with the maximal dose, dashed line is a dose–
volume relation assuming realistic, inhomogeneous dose 
distribution inside OAR.
120
100
80
60
40
20
0
20 40 60 80 100 120
Vo
lu
m
e 
[%
]
Dose [%]
VOaR
VOaR100%
Księga1.indb   183 2008-12-10   11:20:17
184 REP PRACT ONCOL RADIOTHER • 2008 • 13/4/: 182–186
ORIGINAL PAPER
For SDev = 0 the whole tumour volume is cov-
ered homogeneously with the reference dose.
When the critical structures receive 0% of 
the reference dose and the whole tumour vol-
ume is covered by 100% of the isodose and the 
dose distribution inside PTV is homogeneous 
(SDev = 0) then RPI = 1.
RPI = 0 when each OAR volume is covered 
with the homogeneous maximal dose or stan-
dard deviation SDev is equal to 1. 
In clinical practice RPI values are in the 
range of 0 to 1. RPI depends on the particular 
clinical situation and therefore it is a conve-
nient tool for comparison among alternative 
treatment plans prepared for the same patient. 
Treatment plan comparison among different 
patients is ineffi cient when using RPI values.
RESULTS
For better understanding of the RPI concept 
the analysis of two alternative treatment plans 
A and B for selected patient is presented. 
Treatment plans were calculated for one PTV 
contour and fi ve critical structures. Dose vol-
ume histograms A and B were generated for 
each delineated structure (Fig. 2). RPI values 
for plans A and B were 0.328 and 0.403 re-
spectively. Importance factors were the same 
value for all OAR. According to RPI plan B is 
assumed to be preferable; however, the dose 
received by the chiasma optica and neuromy-
elitis optica are higher in comparison to plan 
A. In contrast, the doses delivered to right and 
left eyeballs are lower in plan B.
In both plans, doses delivered to the eye-
balls are below 1.6 Gy (20% of the reference 
dose), which is an acceptable dose value for 
this structure.
Therefore, in this particular situation, im-
portance factor wj (Eq. 1) for this structure is 
equal to 0. RPI values are now 0.519 for plan 
A and 0.493 for plan B. According to the new 
estimated RPI values plan A is recommended 
for treatment.
Similar calculation of RPI value was per-
formed for the pair of treatment plans for 21 
patients. 17 plans, approved by the physician, 
had higher RPI values compared to rejected 
ones. The mean difference in RPI between 
approved and rejected plans was 6.3%. Only 
for 4 cases were approved treatment plans 
characterized by lower RPI values than re-
jected ones. In this group the mean differ-
ence between RPI values was 7.3%. It can be 
concluded that 80% of the approved plans had 
higher RPI than rejected ones. Non-paramet-
ric analysis performed with the test of agree-
ment demonstrated statistically signifi cant 
differences between groups (p = 0.0013). 
The computer program RPIWin® was pre-
pared to facilitate the calculation process. 
The program, created in C++ language, oper-
ates under Windows system. RPIWin® enables 
DVHs to be transferred from the treatment 
planning systems Eclipse Varian and Brain-
Scan BrainLab and RPI values to be calculat-
ed for the reference treatment plan and alter-
native one (Fig. 2).
Fig. 2. DVHs for alternative treatment plans A and B 
prepared for the same patient. Dose to volume relations 
were calculated for all delineated structures introduced to 
the plans. RPI for plan B demonstrates higher value than 
for plan A when weight factors were the same for each 
delineated structure.
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DISCUSSION OF RESULTS
The RPI formula, implemented to the RPI-
Win® algorithm, takes into account relations 
between dose distribution in treated volumes 
and critical structures. The number of DVHs 
for calculation is optional. Only physical dose 
values were analyzed; parameters that infl u-
ence the radiobiological effect (overall treat-
ment time and fraction size) were ignored in 
the RPIWin® algorithm. However, the pur-
pose was to analyze only physical parameters 
(dose value) since they are the background 
for the treatment planning process. The 
RPI formula describes the relation between 
integral doses and dose distributions calcu-
Fig. 3. C++ programming language was used to create 
the RPIWin® application which operates under Windows 
system. DVHs are transferred from TPS versions A – Brain-
Lab and B – Eclipse to RPIWin®. RPI values are calculated 
for dose distribution for chosen anatomical structures and 
PTVs.
lated for the same patient and may be helpful 
in the decision-making process. The results 
confi rm that the value of RPI is in agreement 
with physician’s and dosimetrist’s knowledge 
and provides an objective tool for ranking the 
treatment plans for the same patient. 
The COIN index proposed by Baltas et al. [15] 
became a prototype for the RPI. Unlike other 
parameters widely reported in the literature 
[16], COIN and RPI take into consideration the 
complex relations between PTV and OAR. In a 
review by Feuvret L. et al. [16], a number of in-
dices were presented for treatment plan evalua-
tion. In our study, we did not compare the results 
acquired from RPI calculations with results for 
other indices because, based on our calculations 
[17], the evaluation of the treatment plan qual-
ity is determined by the choice of conformity 
index. Moreover, this work was focused on the 
relative comparison between RPI values for al-
ternative plans for the same patient rather than 
establishing absolute RPI levels, which indicate 
whether the dose distribution is in compliance 
with the treatment protocol.
CONCLUSION
The Radiation Planning Index formula takes 
into account the relation between dose distri-
butions calculated for planning treatment vol-
umes and organs at risk. 
The experiment showed the potential role 
of the RPI index for the comparison of alter-
native treatment plans calculated for the same 
patient and introduces a convenient tool for 
treatment plan selection in clinical practice.
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